Investment Summary

Alta Partners, Bay City Capital and Quilvest Capital Partners Invest In Intarcia Therapeutics

On January 1, 1999, venture capital firm Alta Partners, venture capital firm Bay City Capital and private equity firm Quilvest Capital Partners invested in life science company Intarcia Therapeutics

Investment Highlights
  • This is Alta Partners’ 3rd, Bay City Capital’s 7th and Quilvest Capital Partners’ 1st transaction in the Life Science sector.
  • This is Alta Partners’ 4th, Bay City Capital’s 11th and Quilvest Capital Partners’ 1st transaction in the United States.
  • This is Alta Partners’ 1st, Bay City Capital’s 1st and Quilvest Capital Partners’ 1st transaction in Massachusetts.

Investment Summary

Date 1999-01-01
Target Intarcia Therapeutics
Sector Life Science
Investor(s) Alta Partners
Bay City Capital
Quilvest Capital Partners
Deal Type Venture

Target

Intarcia Therapeutics

Boston, Massachusetts, United States
Intarcia Therapeutics is a biopharmaceutical company applying a targeted approach to the acquisition, development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases. Intarcia Therapeutics is based in Boston, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 3

Investor

Alta Partners

Jackson, Wyoming, United States

Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1996
PE ASSETS 2.6B USD
Size Large
Type Sector Focused
DESCRIPTION

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.


DEAL STATS #
Overall 4 of 59
Sector (Life Science) 3 of 50
Type (Venture) 3 of 48
State (Massachusetts) 1 of 8
Country (United States) 4 of 50
Year (1999) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-01-01 Coloma Wireless

San Francisco, California, United States

Coloma Wireless, a company formed to participate in the FCC's WCS/2.3 GHz spectrum auctions. Coloma purchased spectrum covering 75 million pops.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1999-04-08 Fibex Systems

Fremont, California, United States

Fibex Systems is a pioneer in Integrated Access Digital Loop Carrier (IADLC) products, devices that combine traditional voice services with data services using ATM as the underlying architecture. The acquisition helps service providers transition voice/data traffic to cell/packet networks while maintaining traditional phone business using existing circuit infrastructure.

Sell $445M
Investor

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


DEAL STATS #
Overall 11 of 75
Sector (Life Science) 7 of 54
Type (Venture) 7 of 49
State (Massachusetts) 1 of 10
Country (United States) 11 of 72
Year (1999) 2 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
1999-01-01 LJL Biosystems

Sunnyvale, California, United States

LJL Biosystems, Inc. is a provider of automated instrumentation systems for clinical, research and drug development applications.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
1999-03-01 VNUS Medical Technologies

San Jose, California, United States

VNUS Medical Technologies, Inc. is a provider of medical devices for the minimally invasive treatment of venous reflux.

Buy -
Investor

Quilvest Capital Partners

Paris, France

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1972
PE ASSETS 6.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Quilvest Capital Partners is the private equity investment arm of asset management firm Quilvest. Quilvest Capital Partners invests in private equity and debt funds as well as makes direct investments. The direct investment group looks for opportunities in the US, Europe, and 'opportunistically' in Asia with a preference for buyout, growth capital, and venture transactions. Quilvest Capital Partners will consider both minority and majority positions. Quilvest Capital Partners was established in 1972 and is based Paris.


DEAL STATS #
Overall 1 of 98
Sector (Life Science) 1 of 5
Type (Venture) 1 of 12
State (Massachusetts) 1 of 2
Country (United States) 1 of 43
Year (1999) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2001-09-01 Pashas

Miami Beach, Florida, United States

Pashas is a fast-casual restaurant chain, based in Miami Beach, Flordia.

Buy -